We are a pre-seed biotech startup developing a first-in-class prodrug platform to treat inflammatory diseases at their root.
Our lead program targets Inflammatory Bowel Disease (IBD) and has already demonstrated in vivo proof-of-concept. Unlike conventional therapies that focus on blocking specific pathways or cytokines, our approach tackles the underlying driver of chronic inflammation — oxidative stress. This represents a true paradigm shift in IBD treatment, with a clear path toward expanding into broader autoimmune indications and oncology.
Company Details
- Address
- Erlangen, Bavaria 91058, De
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.roximmune.com
- Keywords
- Salt Lake City.
- HQ
- Erlangen, Bavaria
Roximmune Questions
Roximmune's website is http://www.roximmune.com
Roximmune's LinkedIn profile is https://de.linkedin.com/company/roximmune
Roximmune's industry is
Biotechnology Research
Roximmune's top competitors are
Aster Bioelectronics,
Advanced Medical Solutions,
Exosphere,
Nucleate Germany,
Circular Grain,
Thim Ventures,
Studio Accordé,
Enobyte,
Labor Team,
Oncera.
Roximmune's categories are Biotechnology Research
